Gynuity Health Projects


Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

This article describes the results of a clinical trial seeking to evaluate the use of misoprostol compared to standard oxytocics for treatment of postpartum hemorrhage in women receiving prophylactic oxytocin during labor. The results demonstrate that misoprostol is clinically equivalent to oxytocin when used to stop excessive post-partum bleeding suspected to be due to uterine atony under these circumstances. Read the abstract at The Lancet (Jan 2010), Vol 375(9710), pp 217 – 223.

The "text only" version in this language is not currently available.

  • Topic: Postpartum Hemorrhage
  • Type: Staff Publication
  • Author: Blum, J., Winikoff, B., Raghavan, R., Dabash, R., Cherine Ramadan, M., Dilbaz, B., Dao, B., Durocher, J., Yalvac, S., Diop, A., Dzuba, I.G., Ngoc, N.T.N
  • Published: January 2010

Download PDF in English


Other Languages Available